Scientists have developed a new technology to efficiently isolate a specific subset of gut bacteria from fecal samples that are recognized by IgA antibodies. These 'IgA-coated' bacteria are associated ...

French biotech Innate Pharma is recruiting natural-born killers to target B cell non-Hodgkin lymphoma (B-NHL). | French ...

RNA vaccines saved lives during the COVID-19 pandemic, but older people had less of an immune response to the vaccines than ...

Regeneron (REGN) Pharmaceuticals announced new and updated ... and a pioneering combination of a monoclonal antibody and small interfering RNA, siRNA. Progress on the odronextamab development program ...

Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced new findings related to its ...

STUDENTS at St Mary’s Secondary School, Charleville, are set to benefit from state-of-the-art science facilities made possible through a significant sponsorship by Regeneron Ireland. This ...

RBC Capital lowered the firm’s price target on Regeneron (REGN) to $1,215 from $1,260 but keeps an Outperform rating on the shares. The extent of the stock’s downside following Q3 earnings are ...

“We purchased Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), a biopharmaceutical company that was built on a foundation in basic scientific research and antibody development. The company has ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

Regeneron (REGN) reported $3.72 billion in revenue for the quarter ended September 2024, representing a year-over-year increase of 10.7%. EPS of $12.46 for the same period compares to $11.59 a ...

It's always a worry if you've spotted a mouse indoors or a rat in the backyard. And learning how to get rid of mice or how to get rid of rats can be a challenging and often expensive task at the ...